Magnesium hydroxide
- Generic Name
- Magnesium hydroxide
- Brand Names
- Almacone, Duo Fusion, Gelusil, Maalox Plus, Mi-acid, Mi-acid Double Strength, Mintox Plus, Mylanta, Mylanta Tonight, Pedia-lax Liquid, Pepcid Complete, Rolaids Advanced, Rolaids Reformulated Aug 2006, Rolaids Ultra Strength, Zegerid With Magnesium Hydroxide
- Drug Type
- Small Molecule
- Chemical Formula
- H2MgO2
- CAS Number
- 1309-42-8
- Unique Ingredient Identifier
- NBZ3QY004S
- Background
Magnesium hydroxide is an inorganic compound. It is naturally found as the mineral brucite. Magnesium hydroxide can be used as an antacid or a laxative in either an oral liquid suspension or chewable tablet form.
Additionally, magnesium hydroxide has smoke suppressing and flame retardant properties and is thus used commercially as a fire retardant.
...
- Indication
Magnesium hydroxide can be used as an antacid or a laxative depending on the administered dose.
As an antacid, it is used for the temporary relief of heartburn, upset stomach, sour stomach or acid indigestion.
As a laxative, it is used for the relief of occasional constipation by promoting bowel movements for 30 minutes and up to 6 hours.
- Associated Conditions
- Colic, Constipation, Dyspepsia, Flatulence, Gastric Ulcer, Heartburn, Upset stomach
- Associated Therapies
- Antacid therapy, Gastric Acid Suppression
RELISTOR's Effects on Opioid-Induced Constipation
- First Posted Date
- 2021-06-18
- Last Posted Date
- 2022-05-03
- Lead Sponsor
- Methodist Health System
- Registration Number
- NCT04930237
- Locations
- 🇺🇸
Methodist Moody Brain and Spine Institute, Methodist Dallas Medical Center, Dallas, Texas, United States
The Impact of Air Travel on Passenger Cognitive Functions
- Conditions
- Interventions
- Drug: Melatonin 5 mgDrug: CiticolineDrug: Cytochrome C6Drug: Sodium Chloride Oral ProductDrug: Potassium Chloride Oral ProductDrug: Sodium Citrate Oral ProductDrug: Dextrose Oral Tablet, ChewableDrug: Domperidone Oral ProductDrug: SimethiconeDrug: Acetylsalicylic acidDrug: Magnesium hydroxideDrug: Probiotic Formula
- First Posted Date
- 2021-03-17
- Last Posted Date
- 2021-03-17
- Lead Sponsor
- Dinara Zhumanbayeva
- Target Recruit Count
- 50
- Registration Number
- NCT04802785
Study to Assess the Way the Body Absorbs, Distributes, Breaks Down and Eliminates Radioactive BMS-986256 in Healthy Male Participants
- First Posted Date
- 2020-02-13
- Last Posted Date
- 2022-01-10
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 8
- Registration Number
- NCT04269356
- Locations
- 🇺🇸
Covance - Clinical Pharmacology Services - Madison, Madison, Wisconsin, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.